Ovarian Cancer Essay

BRCA gene may also predict drug resistance in ovarian cancers BRCA 1 and BRCA 2 are gene mutations long associated with high risk for breast and ovarian cancer. Now, researchers at the University of Pennsylvania have found new evidence that it might also predict treatment resistance in ovarian cancers. Why do we care about resistant ovarian tumors? Breast cancer and ovarian cancer are both very serious and devastating diseases. The National Cancer Institute estimates that more than 250 thousand

Question #1 The first primary genetic consideration is that the risk for ovarian cancer is 8%-24% for women with a BRCA mutation. This also implies that any child a woman with this mutation has, will have a 50% chance of inheriting the BRCA gene because they are autosomal dominant genes. (Norris, Spelic, Snyder, & Tinley, 2009, p. 73) A second primary genetic consideration is that BRCA genes are autosomal dominant genes, which means that these genes are equally likely to be passed on to a female

all gynecologic malignancies, ovarian cancer continues to have the highest mortality and is the most difficult to diagnose. In the United States female population, ovarian cancer ranks fifth in absolute mortality among cancer related deaths (13,000/yr). In most reported cases, ovarian cancer, when first diagnosed is in stages III or IV in about 60 to 70% of patients which further complicates treatment of the disease (Barber, 3). Early detection in ovarian cancer is hampered by the lack of appropriate

Ovarian Cancer: Development, symptoms, diagnosis and treatment. Ovarian cancer is the rapid and unregulated division of the ovarian cells and is referred to as the ‘most lethal gynaecologic cancer’ (1). Despite a small lifelong risk of only 1.3% in the general population and only a small proportion of 1.3% of all new cancers, ovarian cancer is the fifth-leading cause of cancer-related death in women (2). This essay will give an insight into the development of this type of cancer, the symptoms, diagnosis

system. Ovarian cancer is located in the ovaries where uncontrollable multiplication of cancer cells occur (Garnick, 2014). Ovarian cancer is the fifth leading cause of death in women in the United States (Su, 2013). There are over 200,000 new cases each year worldwide and it is common in women over the age of 60 (Brain, 2014). The high mortality rate of ovarian cancer is caused by the lack of a screening techniques to detect it early on (Visintin et al, 2008). Epithelial ovarian cancer, borderline

Abstract: Ovarian cancer is known as the silent killer. This type of cancer is rarely caught in the early stages because there are too few symptoms that are often mistaken as other less severe diseases. Ovarian cancer makes up 4% of cancer among woman. Even though it is not hugely common it is the fifth leading cause of cancer death because of the delay in diagnosis (Montagnana, 2011). In this paper I am trying to bring light to a disease that takes over lives often times, too late. Introduction:

Cancer that begins in the ovaries is known as ovarian cancer. It affects 250,000 women world-wide each year, with 20,000 of these women living in the United States. Each year, 140,000 women die of the disease. In 2014, approximately 14,270 died from ovarian cancer in the United States, making it one of the most deadly cancers for women. If detected early, ovarian cancer is highly treatable; 94 percent of women who are diagnosed during stage one live at least five years after diagnosis. Unfortunately

paper on Ovarian Cancer because it is a disease that runs in my family history. My great aunt died of ovarian cancer when she was 73 years old. My two second cousins were diagnosed with ovarian cancer at age 42 and 58. They were diagnosed at the stages 2 and 4 and have survived. This paper will discuss what ovarian cancer is, how it is detected, who it affects and how it could be treated. Definition Cancer is an illness in which irregular cells in the body grow uncontrollably. Ovarian cancer originates

inflammation can help predict ovarian cancer chemoresistance and mortality. Ovarian cancer is the fifth most common cause of death for women in the United States. In 2017, it's estimated that less than 40% of women who are affected by the disease will achieve a successful cure. Some women with the difficult-to-treat disease often have tumors that are not only at advanced stages but also able to resist current chemotherapy drugs. Chemoresistance and metastases in ovarian cancer mean higher mortality rates

Ovarian cancer is ranked the fifth leading cause in cancerous deaths among women. This accounts for the most deaths of any other cancer of the female reproductive system. The American Cancer Society estimates that in the year 2016 about 22,280 women will be newly diagnosed with ovarian cancer and about 14,240 women will die from ovarian cancer (American Cancer Society). Comparatively, small cell ovarian cancer of the hypercalcemic type is a very rare, aggressive form of ovarian cancer seen mainly